Commentary Open Access
Volume 3 | Issue 4 | DOI: https://doi.org/10.33696/immunology.3.105
Novel Combination Treatments for AML
Montserrat Estruch1,2,*, Camilla Vittori1,2, Teresa Muñoz-Montesinos1,2, Kristian Reckzeh1,2,3, Kim Theilgaard-Mönch1,2,3,4,*
- 1The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 2Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 3Novo Nordisk Foundation Centre for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 4Department of Hematology, Rigshospitalet/National University Hospital, University of Copenhagen, Copenhagen, Denmark
Corresponding Author
- Montserrat Estruch, montserrat.alrich@bric.ku.dk
- Kim Theilgaard-Mönch, kim.theilgaard@bric.ku.dk
Received Date: May 03, 2021
Accepted Date: July 26, 2021
Estruch M, Vittori C, Muñoz T, Reckzeh K, Theilgaard-Mönch K. Novel Combination Treatments for AML. J Cell Immunol. 2021; 3(4): 240-245.
Copyright: © 2021 Estruch M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer
Although NK cells are recognized as effector lymphocytes of the innate immune system, they also regulate the adaptive immune response by releasing inflammatory cytokines and developing immunological memory. Unlike other lymphocytes such as T or B cells, NK cells do not express rearrangeable, antigen-specific receptors.
Emerging Role of TRPML1 Mucolipin Endolysosomal Channel in Cancer
The transient receptor potential mucolipin 1 (TRPML1) is an endolysosomal channel belonging to the TRP family. Clinically, mutations of TRPML1 have been responsible for a severe lysosomal storage disorder called mucolipidosis type IV.
Circulating Cell-Free RNA: A New Perspective for Endometrial Cancer
In order to implement the knowledge of cancer to monitor its evolution and setting, in the last decade, new minimally invasive and repeatable samples collection have been developed such as liquid biopsy. Cancer biomarkers originating from tumors can represent the molecular status of the tumor or its metastases which release them directly into body fluids or indirectly due to disruption of tumor/metastatic tissue. These biomarkers are detectable in liquid biopsy.
DNA Nanotechnology Engineered Vesicle for Mimicking Biomolecular Signaling
Bio-inspired strategy is kind of interesting to fabricate devices and perform dynamic operations [1]. Various devices have been made, such as airplane, radar and submarine. In life science, as the fundamental entity, million years’ evolution enables cell becomes the most successful functionality.
Distinct Phosphorylation of STAT1 Confers Distinct DNA Binding and Gene-regulatory Properties
Signal transducer and activator of transcription 1 (STAT1) protein plays a pivotal role in various biological processes especially the regulation of innate and adaptive immune responses. Phosphorylation represents a key step in the activation of STAT1 and its transcriptional outcome. Binding of various extracellular ligands to their specific cell-surface receptors activates different phosphorylation of STAT1 followed by a distinct change of gene expression patterns.